Now that the drug is approved, there will be more upside. There are sizeable milestone payments due. Based on the reports/messages it is valued somewhere around 23.
But I think it may not see $23 very soon. It may take some time. The approved drug will be sold only from June.
http://www.beaconequity.com/xnpt-on-fire-xenoport-is-back-on-the-wave-of-horizant-approval-2011-04-07/#ixzz1IqdYdZUb
Initiated a covered call position.
WBT BOT +1 COVERED XNPT 100 MAY 11 11 CALL/XNPT @9.545 ISE
If this is called, will make $140 after commissions(14% profit). If not called, it will be 7% profit and then I proceed to sell another call.
Calls in MDVN also look interesting. Need more capital for MDVN, so I settled for XNPT.
4/19/11
Bought back the May 11 call for 0.05. and sold another call.
WBT SOLD -1 XNPT 100 JUN 11 10 CALL @.30 PHLX (commision $1.5)
This will further reduce my cost.
Will somebody buy this company? Lot of Biotech mergers and aquicitions going on.
But I think it may not see $23 very soon. It may take some time. The approved drug will be sold only from June.
http://www.beaconequity.com/xnpt-on-fire-xenoport-is-back-on-the-wave-of-horizant-approval-2011-04-07/#ixzz1IqdYdZUb
Initiated a covered call position.
WBT BOT +1 COVERED XNPT 100 MAY 11 11 CALL/XNPT @9.545 ISE
If this is called, will make $140 after commissions(14% profit). If not called, it will be 7% profit and then I proceed to sell another call.
Calls in MDVN also look interesting. Need more capital for MDVN, so I settled for XNPT.
4/19/11
Bought back the May 11 call for 0.05. and sold another call.
WBT SOLD -1 XNPT 100 JUN 11 10 CALL @.30 PHLX (commision $1.5)
This will further reduce my cost.
Will somebody buy this company? Lot of Biotech mergers and aquicitions going on.
No comments:
Post a Comment